Metformin and serious adverse effects
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Attention to known contraindications and intercurrent illness can avoid life-threatening acidosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bailey, C. J., & Turner, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602293340906 · Cited by 1,726
Cited by
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Kovalenko, I. G., Poroshina, T. E., Semenchenko, A. V., Provinciali, M., et al. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.007 · Cited by 402
Metformin slows down aging and extends life span of female SHR mice
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Tyndyk, M. L., Yurova, M. V., Kovalenko, I. G., Poroshina, T. E., et al. (2008) · Cell Cycle · doi:10.4161/cc.7.17.6625 · Cited by 348
Gan, L., Chitturi, S., & Farrell, G. C. (2011) · Current Gerontology and Geriatrics Research · doi:10.1155/2011/831536 · Cited by 135
“The use of metformin in the elderly could be also problematic because of the additional risk of severe life-threatening lactic acidosis (5 per 100,000 prescriptions) [104].”
Establishing pragmatic estimated GFR thresholds to guide metformin prescribing
Shaw, J. S., Wilmot, R. L., & Kilpatrick, E. S. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02221.x · Cited by 90
Metadata
- Authors
- Nisbet, J. C., Sturtevant, J. M., & Prins, J. B.
- Venue
- Medical Journal of Australia
- Publisher
- AMPCo
- Published
- 2004-01
- Volume
- 180
- Issue
- 2
- Pages
- 53-54
- ISSN
- 0025-729X (ISSN-L)
- 1326-5377
- OpenAlex
- W197173709
- Cited by
- 51
- References
- 1
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metformin and serious adverse effects. https://app.cochat.ai/papers/10.5694/j.1326-5377.2004.tb05796.x
- The paper
- Nisbet, J. C., Sturtevant, J. M., & Prins, J. B. (2004). Metformin and serious adverse effects. Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2004.tb05796.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.